0001225208-17-019019.txt : 20171222
0001225208-17-019019.hdr.sgml : 20171222
20171222145738
ACCESSION NUMBER: 0001225208-17-019019
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20171220
FILED AS OF DATE: 20171222
DATE AS OF CHANGE: 20171222
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DeFord John A
CENTRAL INDEX KEY: 0001403373
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-06926
FILM NUMBER: 171272478
MAIL ADDRESS:
STREET 1: C R BARD INC
STREET 2: 730 CENTRAL AVENUE
CITY: MURRAY HILL
STATE: NJ
ZIP: 07974
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BARD C R INC /NJ/
CENTRAL INDEX KEY: 0000009892
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 221454160
STATE OF INCORPORATION: NJ
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 730 CENTRAL AVE
CITY: MURRAY HILL
STATE: NJ
ZIP: 07974
BUSINESS PHONE: 9082778000
MAIL ADDRESS:
STREET 1: 730 CENTRAL AVENUE
CITY: MURRAY HILL
STATE: NJ
ZIP: 07974
4
1
doc4.xml
X0306
4
2017-12-20
0000009892
BARD C R INC /NJ/
BCR
0001403373
DeFord John A
C/O C. R. BARD, INC.
730 CENTRAL AVENUE
MURRAY HILL
NJ
07974
1
Sr. VP Sci Tech and Clin Afrs
Common Stock
2017-12-20
4
M
0
4161.0000
136.3700
A
20950.2316
D
Common Stock
2017-12-20
4
M
0
3767.0000
168.8650
A
24717.2316
D
Common Stock
2017-12-20
4
M
0
3293.0000
186.4250
A
28010.2316
D
Common Stock
2017-12-20
4
M
0
2886.0000
219.5550
A
30896.2316
D
Common Stock
2017-12-20
4
S
0
900.0000
334.1189
D
29996.2316
D
Common Stock
2017-12-20
4
S
0
13207.0000
333.4341
D
16789.2316
D
Common Stock
83.8200
I
401(k) Plan
Option (Right to Buy)
186.4250
2017-12-20
4
M
0
3293.0000
0.0000
D
2025-12-09
Common Stock
3293.0000
6586.0000
D
Option (Right to Buy)
168.8650
2017-12-20
4
M
0
3767.0000
0.0000
D
2024-12-10
Common Stock
3767.0000
3768.0000
D
Option (Right to Buy)
136.3700
2017-12-20
4
M
0
4161.0000
0.0000
D
2023-12-11
Common Stock
4161.0000
0.0000
D
Option (Right to Buy)
219.5550
2017-12-20
4
M
0
2886.0000
0.0000
D
2026-12-14
Common Stock
2886.0000
8658.0000
D
Option exercise and sales are pursuant to a previously disclosed 10b5-1 plan.
Includes 0.0887 shares acquired under the Company's Dividend Reinvestment Plan from February 4, 2017 to August 4, 2017. Includes 0.0020 shares acquired under the Company's Employee Stock Purchase Plan from February 7, 2017 to August 7, 2017.
Represents the weighted average sales price for price increments ranging from $333.97 to $334.30. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
Represents the weighted average sales price for price increments ranging from $332.96 to $333.95. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
Includes 3.904 shares acquired under the Company's 401(k) Plan from May 4, 2017 to August 4, 2017.
Options granted under 2012 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated).
Of this option grant 3,293 options vested on December 9, 2017 and the remaining options vest in two annual installments beginning on December 9, 2018.
Of this option grant 3,767 options vested on December 10, 2017 and the remaining options vest on December 10, 2018.
Options vested on December 11, 2017.
Of this option grant 2,886 options vested on December 14, 2017 and the remaining options vest in three annual installments beginning on December 14, 2018.
Myra McGinley, Attorney-in-Fact
2017-12-22